Table 2.
CTV under-dosage | p-value |
---|---|
Rectum moved anteriorly |
0.029 |
Rectum reduced in volume |
0.01 |
Reduction in the Dice’s coefficient |
0.005 |
Bowel doses increase |
p-value |
Bladder moved anteriorly |
0.01 |
Bladder reduced in volume |
0.0046 |
Rectal doses increase |
p-value |
Rectal volume increased |
0.0026 |
CTV-SIB moved anteriorly |
0.00001 |
Bladder doses increase |
p-value |
Bladder moved posteriorly |
0.01 |
CTV-SIB reduced in volume | 0.01 |
Independent factors contributing to the clinical target volume - simultaneous integrated boost (CTV-SIB) under-dosage and organs at risk (OAR) over-dosage.